The ViaLuxe™ Laser System is designed to reduce IOP, using a micron resolution OCT image-guided femtosecond laser, to non-invasively create customized drainage channels through the trabecular meshwork.
 |
| ViaLuxe Laser System |
The machine has
the following features =
1. ViaLens Patient Interface:
Non-invasively
provides unmatched view and delivery of the femtosecond laser into the
trabecular meshwork angle.
2. ViaVue Gonio Camera:
Gonio imaging
enables the view of complete structures of the angle in all four quadrants.
3. ViaLuxe Laser:
Precisely creates
channels without collateral damage to adjacent tissues.
4. ViaLink:
Bluetooth-connected
tablet displays real-time procedure data and diagnostics.
ViaLase, Inc,
announced the online publication of 24-month safety data from the
first-in-human study of femtosecond laser image-guided high-precision
trabeculotomy (FLigHT) performed with the ViaLase technology in Ophthalmology
Science, a journal of the American Academy of Ophthalmology.
The investigators
in this prospective, non-randomized, single-center, interventional, single-arm
trial evaluated 11 patients (17 eyes) with open-angle glaucoma following FLigHT
treatment, which consisted of the creation of a single channel through the
trabecular meshwork and into Schlemm’s canal. At 24 months post-treatment, the
authors reported no device-related serious adverse events and observed
well-defined channels with no evidence of closure, indicating medium-term
durability.
The study data
demonstrated a mean IOP reduction of 34.6% from a baseline of 22.3 ± 5.5 to
14.5 ± 2.6 mmHg at 24 months.
No comments:
Post a Comment